Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049801324> ?p ?o ?g. }
- W2049801324 endingPage "406" @default.
- W2049801324 startingPage "399" @default.
- W2049801324 abstract "✓ Although gemistocytic astrocytomas are considered slow-growing astrocytomas, they often behave aggressively. To clarify the biological and clinical behavior of these rare tumors, the authors retrospectively identified 59 patients with gemistocytic astrocytoma whose tumors were diagnosed and treated between June, 1976, and July, 1989. Three patients who were lost to follow-up review were excluded, as were two whose original slides could not be obtained and three whose tumors were diagnosed at recurrence or at autopsy. The pathological material of the remaining 51 patients was reviewed using two sets of histological criteria. Thirteen patients (Group A) had “pure” gemistocytic astrocytoma, defined as a glial tumor with more than 60% gemistocytes/high-power field and a background of fibrillary astrocytes. Fifteen patients (Group B) had “mixed” gemistocytic astrocytoma, defined as a glial tumor with 20% to 60% gemistocytes/high-power field and a background of anaplastic astrocytes. Twenty-three tumors did not meet these criteria and were excluded from analysis. The median age of the patients was 48.5 years in Group A and 38.3 years in Group B (p < 0.05). In both groups, the median Kamofsky Performance Scale score was greater than 90%. All patients underwent surgical procedures (four total and 19 partial resections, and five biopsies) and postoperative radiation therapy. The majority also had interstitial brachytherapy, chemotherapy, or both. Ten patients had one reoperation for tumor recurrence and one had two reoperations; other treatments for recurrence included brachytherapy, chemotherapy, and repeat irradiation. All four patients who originally underwent gross total resection are still alive; all five who had a biopsy have died. There was no significant difference in median survival times between groups: 136.5 weeks in Group A (range 10 to 310+ weeks) and 135.6 weeks in Group B (range 31 to 460+ weeks). Analysis of all 28 patients showed a better prognosis for patients less than 50 years of age (185 vs. 36 weeks survival time; p < 0.001), patients with preoperative symptoms lasting for more than 6 months (228.1 vs. 110.2 weeks survival time; p < 0.05), and patients with seizures as the first symptom (185.7 vs. 80 weeks survival time; p < 0.01). Survival time did not correlate with the presence of perivascular lymphocytic infiltration. The authors conclude that the presence of at least 20% gemistocytes in a glial neoplasm is a poor prognostic sign, irrespective of the pathological background. It is proposed that gemistocytic astrocytomas be classified with anaplastic astrocytomas and treated accordingly." @default.
- W2049801324 created "2016-06-24" @default.
- W2049801324 creator A5001979226 @default.
- W2049801324 creator A5046264008 @default.
- W2049801324 creator A5057121260 @default.
- W2049801324 creator A5057936028 @default.
- W2049801324 date "1991-03-01" @default.
- W2049801324 modified "2023-10-02" @default.
- W2049801324 title "Gemistocytic astrocytomas: a reappraisal" @default.
- W2049801324 cites W1508981216 @default.
- W2049801324 cites W1570056825 @default.
- W2049801324 cites W1790847442 @default.
- W2049801324 cites W1819336032 @default.
- W2049801324 cites W1966055617 @default.
- W2049801324 cites W1972532120 @default.
- W2049801324 cites W1973686381 @default.
- W2049801324 cites W1986927910 @default.
- W2049801324 cites W1995197521 @default.
- W2049801324 cites W2006676866 @default.
- W2049801324 cites W2015120686 @default.
- W2049801324 cites W2033128037 @default.
- W2049801324 cites W2036560693 @default.
- W2049801324 cites W2036811161 @default.
- W2049801324 cites W2041212687 @default.
- W2049801324 cites W2044455841 @default.
- W2049801324 cites W2044992794 @default.
- W2049801324 cites W2046894472 @default.
- W2049801324 cites W2061134998 @default.
- W2049801324 cites W2061554178 @default.
- W2049801324 cites W2077019827 @default.
- W2049801324 cites W2079618669 @default.
- W2049801324 cites W2082102301 @default.
- W2049801324 cites W2087294820 @default.
- W2049801324 cites W2090315608 @default.
- W2049801324 cites W2094202296 @default.
- W2049801324 cites W2102628178 @default.
- W2049801324 cites W2109937583 @default.
- W2049801324 cites W2110431989 @default.
- W2049801324 cites W2117322456 @default.
- W2049801324 cites W2126761367 @default.
- W2049801324 cites W2130100096 @default.
- W2049801324 cites W2143594378 @default.
- W2049801324 cites W2161978888 @default.
- W2049801324 cites W2163342290 @default.
- W2049801324 cites W2415212157 @default.
- W2049801324 cites W2886441795 @default.
- W2049801324 cites W4293241248 @default.
- W2049801324 doi "https://doi.org/10.3171/jns.1991.74.3.0399" @default.
- W2049801324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1993905" @default.
- W2049801324 hasPublicationYear "1991" @default.
- W2049801324 type Work @default.
- W2049801324 sameAs 2049801324 @default.
- W2049801324 citedByCount "131" @default.
- W2049801324 countsByYear W20498013242012 @default.
- W2049801324 countsByYear W20498013242013 @default.
- W2049801324 countsByYear W20498013242014 @default.
- W2049801324 countsByYear W20498013242016 @default.
- W2049801324 countsByYear W20498013242017 @default.
- W2049801324 countsByYear W20498013242018 @default.
- W2049801324 countsByYear W20498013242019 @default.
- W2049801324 countsByYear W20498013242020 @default.
- W2049801324 countsByYear W20498013242021 @default.
- W2049801324 countsByYear W20498013242022 @default.
- W2049801324 countsByYear W20498013242023 @default.
- W2049801324 crossrefType "journal-article" @default.
- W2049801324 hasAuthorship W2049801324A5001979226 @default.
- W2049801324 hasAuthorship W2049801324A5046264008 @default.
- W2049801324 hasAuthorship W2049801324A5057121260 @default.
- W2049801324 hasAuthorship W2049801324A5057936028 @default.
- W2049801324 hasConcept C126838900 @default.
- W2049801324 hasConcept C141071460 @default.
- W2049801324 hasConcept C142724271 @default.
- W2049801324 hasConcept C207886595 @default.
- W2049801324 hasConcept C2776694085 @default.
- W2049801324 hasConcept C2777416452 @default.
- W2049801324 hasConcept C2778227246 @default.
- W2049801324 hasConcept C2778880634 @default.
- W2049801324 hasConcept C2779083369 @default.
- W2049801324 hasConcept C502942594 @default.
- W2049801324 hasConcept C509974204 @default.
- W2049801324 hasConcept C71924100 @default.
- W2049801324 hasConceptScore W2049801324C126838900 @default.
- W2049801324 hasConceptScore W2049801324C141071460 @default.
- W2049801324 hasConceptScore W2049801324C142724271 @default.
- W2049801324 hasConceptScore W2049801324C207886595 @default.
- W2049801324 hasConceptScore W2049801324C2776694085 @default.
- W2049801324 hasConceptScore W2049801324C2777416452 @default.
- W2049801324 hasConceptScore W2049801324C2778227246 @default.
- W2049801324 hasConceptScore W2049801324C2778880634 @default.
- W2049801324 hasConceptScore W2049801324C2779083369 @default.
- W2049801324 hasConceptScore W2049801324C502942594 @default.
- W2049801324 hasConceptScore W2049801324C509974204 @default.
- W2049801324 hasConceptScore W2049801324C71924100 @default.
- W2049801324 hasIssue "3" @default.
- W2049801324 hasLocation W20498013241 @default.
- W2049801324 hasLocation W20498013242 @default.
- W2049801324 hasOpenAccess W2049801324 @default.
- W2049801324 hasPrimaryLocation W20498013241 @default.